Full Text (PDF)
Review Article

Advancements in Management of Diabeties Mellitus

Dhanya Joseph, Keerthi Kalabathula, Y. Venkata Vanaja, A. Hemavathi null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Indian Journal of Surgical Nursing 12(2):p 65-74, May-August 2023. | DOI: 10.21088/ijsn.2277.467X.12223.3

How Cite This Article:

Kalabathula K, Joseph D, Vanaja YV, et al. Advancements in management of diabetes mellitus. Indian J Surg Nurs. 2023;12(2):65–74.

Timeline

Received : March 20, 2023         Accepted : April 24, 2023          Published : May 30, 2023

Abstract

Introduction: Diabetes is a group of metabolic disease in which there are high blood sugars for a prolonged period, if untreated leads to many life-threatening complications. Diabetes is due to either the pancreas not producing enough insulin or the cells of the body not responding properly to insulin.

Definition: Diabetes is a chronic metabolic disease characterized by elevated levels of blood glucose which leads over time to serious damage to heart, blood vessels, eyes, kidney and nerves.

Incidence:

• IDF Global Diabetes Atlas provides estimated and projected prevalence rate of diabetes around the world. Its most recent data from 2021 shows that China has the largest number of adults with diabetes aged 20-79 years followed by India and Pakistan.

• 463 million people globally are diagnosed with diabetes. In that 88 million are from south east Asia, out of that 88 million, 77 million are from India.

• The most affected rate in India is the economically and epidemiologically advanced states that is Kerala and Tamil Nadu. Kerala is the diabetic capital of India.

• In Telangana 26% above 30 years are diagnosed and are at high risk. Total 8% of the people of whole Telangana are diabetics.

• The incidence of diabetes has been increasing significantly on a global level. According to the latest statistics issued by the International Diabetes Federation, the number of adult diabetes cases reached 463 million worldwide in 2019, and it is anticipated to rise to 700 million cases by 2045. With the growing prevalence of diabetes, the economic cost has become burden some. The total cost of US- diagnosed diabetes in 2017 was estimated by the American Diabetes Association to be $327 billion, with an average individual expense of $16,752 er year. These figures demonstrate the significance of diabetes and encourage scientists and researchers to develop innovative solutions to make the lives of diabetics easier.


References

  • 1.   • Wang YF, Jia W. Continuous glucose monitoring. Singapore: Springer; 2018.
  • 2.   • Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA. 2021;325(22):2266–75.
  • 3.   • Diabetes update: continuous glucose monitoring yields better HbA1C control. Am J Nurs. 2021;121(9):16.
  • 4.   • Seitz WR. Continuous glucose monitoring sensors: past, present and future algorithmic challenges. Sensors (Basel). 2016;16(12):2093.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

Whether all authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Kalabathula K, Joseph D, Vanaja YV, et al. Advancements in management of diabetes mellitus. Indian J Surg Nurs. 2023;12(2):65–74.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Received Accepted Published
March 20, 2023 April 24, 2023 May 30, 2023

DOI: 10.21088/ijsn.2277.467X.12223.3

Keywords

DiabetesMetabolic diseaseHigh blood sugarsLife-threateningPancreasInsulin

Article Level Metrics

Last Updated

Monday 22 June 2026, 03:44:50 (IST)


742

Accesses

7
147
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 20, 2023
Accepted April 24, 2023
Published May 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Access this article



Share